Drug Development for Pediatric Populations: Regulatory Aspects

Pediatric aspects are nowadays integrated early in the development process of a new drug. The stronger enforcement to obtain pediatric information by the regulatory agencies in recent years resulted in an increased number of trials in children. Specific guidelines and requirements from, in particula...

Descripción completa

Detalles Bibliográficos
Autores principales: Zisowsky, Jochen, Krause, Andreas, Dingemanse, Jasper
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967144/
https://www.ncbi.nlm.nih.gov/pubmed/27721363
http://dx.doi.org/10.3390/pharmaceutics2040364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967144/
https://www.ncbi.nlm.nih.gov/pubmed/27721363
http://dx.doi.org/10.3390/pharmaceutics2040364

Ejemplares similares